Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
|ClinicalTrials.gov Identifier: NCT01113853|
Recruitment Status : Completed
First Posted : April 30, 2010
Last Update Posted : May 3, 2010
Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients.
The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment|
|Study Start Date :||January 2007|
|Study Completion Date :||January 2010|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01113853
|Pediatric Department University of Verona|
|Verona, Italy, 37100|
|Principal Investigator:||Giorgio L Piacentini, MD||Universita di Verona|